Estrella Immunopharma, Inc. Common Stock (ESLA) is a publicly traded Healthcare sector company. As of July 24, 2026, ESLA trades at $0.89 with a market cap of $32.75M and a P/E ratio of -2.22. ESLA moved +16.43% today. Year to date, ESLA is -51.00%; over the trailing twelve months it is -15.07%. Its 52-week range spans $0.73 to $3.15. Rallies surfaces ESLA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Estrella Immunopharma, Inc. Common Stock (ESLA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ESLA moved +16.43% today.
| Metric | Value |
|---|---|
| Price | $0.89 |
| Market Cap | $32.75M |
| P/E Ratio | -2.22 |
| EPS | $-0.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.15 |
| 52-Week Low | $0.73 |
| Volume | 377 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-13.06M |
| Gross Margin | 0.00% |
ESLA analyst coverage data. Average price target: $0.00.